MedTrace Logo

Evaluation of a Mobile App to Promote Social Support for Oncology Patients

NCT04331678 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 230

Last updated 2023-12-18

No results posted yet for this study

Summary

Our study will evaluate patient and caregiver use of a new mobile application (app) to support patients undergoing chemotherapy treatment for cancer.

Conditions

  • Chemotherapy Effect

Interventions

BEHAVIORAL

Comparator App

Participants will download and agree to use the study app at least once per week during the 3-month intervention period. The app allows participants to invite a network of friends and family to provide emotional and logistical support during their treatment.

Sponsors & Collaborators

  • Pfizer

    collaborator INDUSTRY

  • Emory University

    collaborator OTHER

  • West Cancer Center

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-12
Primary Completion
2021-10-24
Completion
2021-10-24

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04331678 on ClinicalTrials.gov